# Chr. Augustinus Fabrikker

> Chr. Augustinus Fabrikker is a VC fund backing Health Care and Software. See 18 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Copenhagen, Denmark
- Total investments: 18
- Last investment: Feb 2026
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/augustinusfabrikker/
- Website: https://augustinusfabrikker.dk/en/

Chr. Augustinus Fabrikker is a VC fund in Copenhagen focused on Health Care and Software. Chr. Augustinus Fabrikker operates as an investment management firm with a core focus on dedicated ownership of Danish businesses. Founded in 1750, Chr. Augustinus Fabrikker has a capital base of more than 30 billion, a significant player in the Danish business community. It is owned by the Augustinus Foundation, which is one of Denmark'slargest cultural foundations, and also makes significant contributions to research and social initiatives.

## Contacts

5 contacts available for Chr. Augustinus Fabrikker. Shizune tracks 1 team members at Chr. Augustinus Fabrikker. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/chr-augustinus-fabrikker?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $16M–$27M |
| Series B | $21M–$78M |
| Series C | $44M–$80M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 17% |
| Software | 2 | 11% |
| Medical Device | 2 | 11% |
| Machine Learning | 2 | 11% |
| Artificial Intelligence | 2 | 11% |

27 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 22% |
| Series B | 4 | 22% |
| Series C | 2 | 11% |
| Venture - Series Unknown | 2 | 11% |
| Series D | 1 | 6% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ole Augustinus | Founder | 0 | https://shizune.co/investors/profile/ole-augustinus |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Dawn Health | Dawn Health is a digital health company offering life-changing digital health therapies driving improved patient outcomes beyond the pill. The company is enabling to design, develop, and service medical device software. They help people live better and longer lives through technology and aim to accelerate digital health globally through strategicconsulting and the development of innovative digital health products together with their partners. As MedTech specialists, they create life-changing solutions with a strategic focus on digital health, SaMD, GxP software, and IoT within healthcare. Dawn Health envisions a time where digital health solutions will revolutionize how people worldwide achieve higher standards of health, and access services to promote and protect their health and well-being. The company has a global ambition to be the preferred Digital Health Partner to the life science industry, and through their partnerships and ventures, to impact one million lives by 2030 through digital interventions. | $25.6M | Venture - Series Unknown | Feb 10, 2026 |  |
| Dawn Health | Dawn Health is a digital health company offering life-changing digital health therapies driving improved patient outcomes beyond the pill. The company is enabling to design, develop, and service medical device software. They help people live better and longer lives through technology and aim to accelerate digital health globally through strategicconsulting and the development of innovative digital health products together with their partners. As MedTech specialists, they create life-changing solutions with a strategic focus on digital health, SaMD, GxP software, and IoT within healthcare. Dawn Health envisions a time where digital health solutions will revolutionize how people worldwide achieve higher standards of health, and access services to promote and protect their health and well-being. The company has a global ambition to be the preferred Digital Health Partner to the life science industry, and through their partnerships and ventures, to impact one million lives by 2030 through digital interventions. | $13M |  | May 05, 2025 |  |
| Eupry | Eupry is actively servicing customers in +25 countries with state-of-the-art automated compliance solutions for life science companies. | $23.8M | Series A | Dec 20, 2024 |  |
| Eupry | Eupry is actively servicing customers in +25 countries with state-of-the-art automated compliance solutions for life science companies. | $23.8M | Series A | Dec 20, 2024 |  |
| Podimo | Podimoa is an open podcast platform that offers a subscription service for creators. Founded in 2019, Podimo is a podcast and short-form audio platform which offers personalized recommendations to listeners, while offering creators a share of revenue via premium subscriptions. Co-founded by Morten Strunge, Nikolaj Koppel, Andreas Sachse, EvaLægdsgaard, and Sverre Dueholm, Podimo is hoping to capitalize on the rise in consumption in podcasts. | $48.4M | Venture - Series Unknown | Dec 21, 2023 |  |
| Corti | Trusted by leading healthcare providers to enhance millions of patient interactions, with seamless integration into your workflow. | $59.6M | Series B | Sep 20, 2023 |  |
| Lunar | Lunar is a digital challenger bank that offers a mobile-based banking app that helps consumers control their personal finances.It provides a range of financial services including insurance, savings, budgets, loans, and investments via a mobile application. The company also operates a banking license and launched a challenger bank providing freeaccounts and a subscription-based service called Lunar Premium. Lunar aims to roll out full personal and business banking operations and strive towards profitability in profitable banking markets. Up to date, the company has raised €104 million from investors including Seed Capital, Greyhound Capital, Socii Capital and Chr. Augustinus Fabrikker. It has offices in Aarhus, Copenhagen, Stockholm, and Oslo, with a headcount of more than 180 employees.The Copenhagen, Hovedstaden-based company was founded in 2015 by Ken Villum Klausen. | $38M | Series D | Feb 09, 2023 |  |
| Podimo | Podimoa is an open podcast platform that offers a subscription service for creators. Founded in 2019, Podimo is a podcast and short-form audio platform which offers personalized recommendations to listeners, while offering creators a share of revenue via premium subscriptions. Co-founded by Morten Strunge, Nikolaj Koppel, Andreas Sachse, EvaLægdsgaard, and Sverre Dueholm, Podimo is hoping to capitalize on the rise in consumption in podcasts. | $58.5M | Series B | Sep 14, 2022 |  |
| Veo | Veo is a solution for recording and watching sports without a cameraman. It only requires a minimal setup to be able to share your sport. Veo enables football clubs of all sizes to automatically record, edit, and stream their matches. | $80.2M | Series C | Jun 07, 2022 |  |
| Dawn Health | Dawn Health is a digital health company offering life-changing digital health therapies driving improved patient outcomes beyond the pill. The company is enabling to design, develop, and service medical device software. They help people live better and longer lives through technology and aim to accelerate digital health globally through strategicconsulting and the development of innovative digital health products together with their partners. As MedTech specialists, they create life-changing solutions with a strategic focus on digital health, SaMD, GxP software, and IoT within healthcare. Dawn Health envisions a time where digital health solutions will revolutionize how people worldwide achieve higher standards of health, and access services to promote and protect their health and well-being. The company has a global ambition to be the preferred Digital Health Partner to the life science industry, and through their partnerships and ventures, to impact one million lives by 2030 through digital interventions. | $25M | Series A | Dec 01, 2021 |  |

10 of 18 investments shown.

## Co-investors
- [Export and Investment Fund](https://shizune.co/investors/profile/export-and-investment-fund) — VC Fund, 8 deals together
- [Seed Capital](https://shizune.co/investors/profile/seed-capital) — VC Fund, 6 deals together
- [Greyhound Capital](https://shizune.co/investors/profile/greyhound-capital) — VC Fund, 4 deals together
- [Socii Capital](https://shizune.co/investors/profile/socii-capital) — VC Fund, 4 deals together
- [Headline](https://shizune.co/investors/profile/headlinevc) — VC Fund, 3 deals together
- [Heartcore Capital](https://shizune.co/investors/profile/heartcore-capital) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Vaekstfonden](https://shizune.co/investors/profile/v%C3%A6kstfonden) — VC Fund
- [PSV](https://shizune.co/investors/profile/preseed-innovation) — VC Fund
- [Seed Capital](https://shizune.co/investors/profile/seed-capital) — VC Fund

## Featured in investor lists
- [All VC Funds in Denmark](https://shizune.co/investors/vc-funds-denmark)
- [All Investors in Denmark](https://shizune.co/investors/investors-denmark)
- [Health Care Investors in Denmark](https://shizune.co/investors/health-care-investors-denmark)
- [Health Care VC Funds in Denmark](https://shizune.co/investors/health-care-vc-funds-denmark)
- [SaaS VC Funds in Denmark](https://shizune.co/investors/saas-vc-funds-denmark)
- [Medical Device Investors in Denmark](https://shizune.co/investors/medical-device-investors-denmark)

## FAQ

### What does Chr. Augustinus Fabrikker invest in?

Chr. Augustinus Fabrikker invests primarily in Health Care, Software and Medical Device startups, most often at Series A and Series B stage. Most of the 18 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Chr. Augustinus Fabrikker's check size?

Chr. Augustinus Fabrikker typically joins rounds of $16M–$27M at Series A, $21M–$78M at Series B and $44M–$80M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Chr. Augustinus Fabrikker participates in.

### How do I contact Chr. Augustinus Fabrikker?

Public channels for Chr. Augustinus Fabrikker include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Chr. Augustinus Fabrikker?

The team at Chr. Augustinus Fabrikker includes Ole Augustinus (Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co